These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30597765)

  • 1. Thalidomide Teratogenic Effects Linked to Degradation of SALL4: After 60 years, researchers have now shed light on the mechanism underlying thalidomide's devastating teratogenic effects.
    Am J Med Genet A; 2018 Dec; 176(12):2538-2539. PubMed ID: 30597765
    [No Abstract]   [Full Text] [Related]  

  • 2. The teratogenic effects of thalidomide on limbs.
    Vargesson N
    J Hand Surg Eur Vol; 2019 Jan; 44(1):88-95. PubMed ID: 30335598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization.
    Kenyon BM; Browne F; D'Amato RJ
    Exp Eye Res; 1997 Jun; 64(6):971-8. PubMed ID: 9301478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide's early effects.
    Basson M
    Nat Med; 2010 Apr; 16(4):372. PubMed ID: 20376040
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome.
    Donovan KA; An J; Nowak RP; Yuan JC; Fink EC; Berry BC; Ebert BL; Fischer ES
    Elife; 2018 Aug; 7():. PubMed ID: 30067223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peek into the atomic details of thalidomide's clinical effects.
    Bhogaraju S; Dikic I
    Nat Struct Mol Biol; 2014 Sep; 21(9):739-40. PubMed ID: 25192261
    [No Abstract]   [Full Text] [Related]  

  • 7. Thalidomide-induced teratogenesis: history and mechanisms.
    Vargesson N
    Birth Defects Res C Embryo Today; 2015 Jun; 105(2):140-56. PubMed ID: 26043938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of thalidomide use in birth defects in Brazil.
    Sales Luiz Vianna F; Kowalski TW; Fraga LR; Sanseverino MT; Schuler-Faccini L
    Eur J Med Genet; 2017 Jan; 60(1):12-15. PubMed ID: 27638330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide's chirality.
    Wnendt S; Zwingenberger K
    Nature; 1997 Jan; 385(6614):303-4. PubMed ID: 9002511
    [No Abstract]   [Full Text] [Related]  

  • 10. Structural studies reveal thalidomide's mechanism of action and clinical effects: crystal clear or clearly complexed?
    Ley AM; Chau CH; Figg WD
    Cancer Biol Ther; 2015; 16(1):19-20. PubMed ID: 25692618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypnotic effect of thalidomide is independent of teratogenic ubiquitin/proteasome pathway.
    Hirose Y; Kitazono T; Sezaki M; Abe M; Sakimura K; Funato H; Handa H; Vogt KE; Yanagisawa M
    Proc Natl Acad Sci U S A; 2020 Sep; 117(37):23106-23112. PubMed ID: 32848052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis-related genes and thalidomide teratogenesis in humans: an approach on genetic variation and review of past in vitro studies.
    Kowalski TW; Fraga LR; Tovo-Rodrigues L; Sanseverino MTV; Hutz MH; Schuler-Faccini L; Vianna FSL
    Reprod Toxicol; 2017 Jun; 70():133-140. PubMed ID: 28161597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate.
    Matyskiela ME; Couto S; Zheng X; Lu G; Hui J; Stamp K; Drew C; Ren Y; Wang M; Carpenter A; Lee CW; Clayton T; Fang W; Lu CC; Riley M; Abdubek P; Blease K; Hartke J; Kumar G; Vessey R; Rolfe M; Hamann LG; Chamberlain PP
    Nat Chem Biol; 2018 Oct; 14(10):981-987. PubMed ID: 30190590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of thalidomide's history and current dermatological applications.
    Perri AJ; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A looking glass perspective: thalidomide and cyclopamine.
    Gaffield W; Incardona JP; Kapur RP; Roelink H
    Cell Mol Biol (Noisy-le-grand); 1999 Jul; 45(5):579-88. PubMed ID: 10512190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human teratogens and genetic phenocopies. Understanding pathogenesis through human genes mutation.
    Cassina M; Cagnoli GA; Zuccarello D; Di Gianantonio E; Clementi M
    Eur J Med Genet; 2017 Jan; 60(1):22-31. PubMed ID: 27639441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide: an old sedative-hypnotic with anticancer activity?
    Gasparini G; Morabito A; Magnani E; Gattuso D; Capaccetti B; Alberti AM
    Curr Opin Investig Drugs; 2001 Sep; 2(9):1302-8. PubMed ID: 11717819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Observatios on the teratogenic repercussions of thalidomide in the mouse and rabbit].
    GIROUD A; TUCHMANN-DUPLESSIS H; MERCIER-PAROT L
    C R Seances Soc Biol Fil; 1962; 156():765-8. PubMed ID: 13948223
    [No Abstract]   [Full Text] [Related]  

  • 19. [HOW TO EXPLAIN THE TERATOGENIC ACTION OF THALIDOMIDE].
    ANDRIEU R
    Clinique (Paris); 1963 Sep; 58():509-11. PubMed ID: 14089608
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thalidomide: a teratogenic drug?].
    AIAZZI MANCINI M
    Riforma Med; 1962 Jun; 76():705-7. PubMed ID: 13859774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.